Functional determinants of the Epstein-Barr virus protease
- 3 August 2001
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 311 (1) , 217-228
- https://doi.org/10.1006/jmbi.2001.4854
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Virostatic Therapy for Advanced Lymphoproliferation Associated with the Epstein–Barr Virus in an HIV-Infected PatientNew England Journal of Medicine, 2000
- The Herpesvirus Proteases as Targets for Antiviral ChemotherapyAntiviral Chemistry and Chemotherapy, 2000
- Acyclovir for Treatment of Infectious Mononucleosis: A Meta-analysisScandinavian Journal of Infectious Diseases, 1999
- Crystal structure of varicella-zoster virus proteaseProceedings of the National Academy of Sciences, 1997
- Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic TriadCell, 1996
- Unique fold and active site in cytomegalovirus proteaseNature, 1996
- A new serine-protease fold revealed by the crystal structure of human cytomegalovirus proteaseNature, 1996
- Three-dimensional structure of human cytomegalovirus proteaseNature, 1996
- In vitro Proteolytic Activity and Active‐Site Identification of the Human Cytomegalovirus ProteaseEuropean Journal of Biochemistry, 1994
- Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replicationAntimicrobial Agents and Chemotherapy, 1991